The Peptide Lie: What a Drug Developer Reveals About the Compounds Everyone Is Injecting | Dr Leigh Baxt

The surge in the use of non-FDA-approved peptide therapies for wellness and longevity presents significant, unquantifiable health risks due to a lack of rigorous human clinical data. While peptides can be legitimate therapeutic tools, many compounds currently marketed for "research purposes only" bypass the essential 10-15 year drug development process, which includes critical safety pharmacology and toxicology testing. Dr. Leigh Baxt, a scientist specializing in drug development, notes that these unregulated products often lack mechanistic understanding and rely on basic cellular or animal studies that do not translate to human safety. Consumers frequently conflate anecdotal success stories with proven efficacy, ignoring the potential for harmful side effects like unregulated cell proliferation or angiogenesis. Without established regulatory standards or scientific consensus, these self-administered injections remain an experimental, high-risk endeavor for the general public.